METTL3 and neoplasm: RNA methylation-targeting agents disrupt the survival of tumor cells by modulating three core components of the epitranscriptomic machinery that include demethylases (FTO), methyltransferases (METTL3, PRMT5) and oligonucleotide-based regulators of methylation enzymes.